US Stock MarketDetailed Quotes

CNTG Centogene

Watchlist
  • 0.4610
  • -0.0190-3.96%
Close Apr 24 16:00 ET
  • 0.4800
  • +0.0190+4.12%
Post 16:37 ET
12.85MMarket Cap-301P/E (TTM)

About Centogene Company

Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.

Company Profile

SymbolCNTG
Company NameCentogene
Listing DateNov 7, 2019
Issue Price14.00
Founded2018
CEOMs. Kim Stratton
MarketNASDAQ
Employees808
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressAm Strande 7
CityRostock
ProvinceMecklenburg-Vorpommern
CountryGermany
Zip Code18055
Phone49-381-80113400

Company Executives

  • Name
  • Position
  • Salary
  • Kim Stratton
  • Chief Executive Officer and Member of the Management Board
  • 1.53M
  • Jose Miguel Coego Rios
  • Chief Financial Officer
  • 421.00K
  • Professor Peter Bauer
  • Chief Medical and Genomic Officer
  • 174.00K
  • Bettina Goerner
  • Chief Data Officer
  • --
  • Patrice P. Denefle, PhD
  • Chief Scientific Officer
  • --
  • Dr. Andreas Busch, PhD
  • Vice-Chairman of the Supervisory Board
  • 124.00K
  • Peer M. Schatz
  • Chairman of the Supervisory Board
  • 984.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg